Evidence map›Paper›PMID 37583270›Full record

ArticleEpilepsia open2023

Landscape of genetic infantile epileptic spasms syndrome-A multicenter cohort of 124 children from India.

Balamurugan Nagarajan, Vykuntaraju K Gowda, Sangeetha Yoganathan, Indar Kumar Sharawat, Kavita Srivastava, Nitish Vora, Rahul Badheka, Sumita Danda, Umesh Kalane, Anupriya Kaur and 14 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Epilepsia open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. NovelHuman mutation · 2026
    Article
  5. Infantile epileptic spasms syndrome: Mechanisms and therapeutic approaches.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Genetic implication of GABAFrontiers in pharmacology · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Observational
  17. Review
  18. Review
  19. Article
  20. Genes · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 1 country.

Balamurugan NagarajanPediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.ORCID 0000-0003-4315-9882
Vykuntaraju K GowdaDepartment of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bengaluru, India.
Sangeetha YoganathanPediatric Neurology Unit, Department of Neurological Sciences, Christian Medical College, Vellore, India.
Indar Kumar SharawatPediatric Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, Rishikesh, India.ORCID 0000-0002-7003-7218
Kavita SrivastavaPediatric Neurology Unit, Department of Pediatrics, Bharati Vidyapeeth Deemed University Medical College, Pune, India.
Nitish VoraRoyal Institute of Child Neurosciences, Ahmedabad, India.
Rahul BadhekaRoyal Institute of Child Neurosciences, Ahmedabad, India.
Sumita DandaDepartment of Medical Genetics, Christian Medical College, Vellore, India.
Umesh KalanePediatric Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, Rishikesh, India.
Anupriya KaurGenetics and Metabolic Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Priyanka MadaanPediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sanjiv MehtaRoyal Institute of Child Neurosciences, Ahmedabad, India.
Sandeep NegiPediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Prateek Kumar PandaPediatric Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, Rishikesh, India.ORCID 0000-0001-7831-9271
Surekha RajadhyakshaPediatric Neurology Unit, Department of Pediatrics, Bharati Vidyapeeth Deemed University Medical College, Pune, India.ORCID 0000-0003-2719-7440
Arushi Gahlot SainiPediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Lokesh SainiPediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.ORCID 0000-0003-3153-0736
Siddharth ShahRoyal Institute of Child Neurosciences, Ahmedabad, India.
Varunvenkat M SrinivasanDepartment of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bengaluru, India.
Renu SutharPediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Maya ThomasPediatric Neurology Unit, Department of Neurological Sciences, Christian Medical College, Vellore, India.
Sameer VyasDivision of Neuroimaging and Interventional Neuroradiology, Department of Radiodiagnosis and Imaging, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Naveen SankhyanPediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Jitendra Kumar SahuPediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.ORCID 0000-0001-5194-9951
Post Graduate Institute of Medical Education and Research · INInstitute of Neurosciences Kolkata · INAll India Institute of Medical Sciences Rishikesh · INChristian Medical College, Vellore · INBharati Vidyapeeth Deemed University · INIndira Gandhi Institute of Child Health · INAll India Institute of Medical Sciences Jodhpur · INAmrita Institute of Medical Sciences and Research Centre · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveLiterature on the genotypic spectrum of Infantile Epileptic Spasms Syndrome (IESS) in children is scarce in developing countries. This multicentre collaboration evaluated the genotypic and phenotypic landscape of genetic IESS in Indian children.

methodsBetween January 2021 and June 2022, this cross-sectional study was conducted at six centers in India. Children with genetically confirmed IESS, without definite structural-genetic and structural-metabolic etiology, were recruited and underwent detailed in-person assessment for phenotypic characterization. The multicentric data on the genotypic and phenotypic characteristics of genetic IESS were collated and analyzed.

resultsOf 124 probands (60% boys, history of consanguinity in 15%) with genetic IESS, 105 had single gene disorders (104 nuclear and one mitochondrial), including one with concurrent triple repeat disorder (fragile X syndrome), and 19 had chromosomal disorders. Of 105 single gene disorders, 51 individual genes (92 variants including 25 novel) were identified. Nearly 85% of children with monogenic nuclear disorders had autosomal inheritance (dominant-55.2%, recessive-14.2%), while the rest had X-linked inheritance. Underlying chromosomal disorders included trisomy 21 (n = 14), Xq28 duplication (n = 2), and others (n = 3). Trisomy 21 (n = 14), ALDH7A1 (n = 10), SCN2A (n = 7), CDKL5 (n = 6), ALG13 (n = 5), KCNQ2 (n = 4), STXBP1 (n = 4), SCN1A (n = 4), NTRK2 (n = 4), and WWOX (n = 4) were the dominant single gene causes of genetic IESS. The median age at the onset of epileptic spasms (ES) and establishment of genetic diagnosis was 5 and 12 months, respectively. Pre-existing developmental delay (94.3%), early age at onset of ES (<6 months; 86.2%), central hypotonia (81.4%), facial dysmorphism (70.1%), microcephaly (77.4%), movement disorders (45.9%) and autistic features (42.7%) were remarkable clinical findings. Seizures other than epileptic spasms were observed in 83 children (66.9%). Pre-existing epilepsy syndrome was identified in 21 (16.9%). Nearly 60% had an initial response to hormonal therapy. SIGNIFICANCE: Our study highlights a heterogenous genetic landscape and phenotypic pleiotropy in children with genetic IESS.

Indexed as

Down SyndromeSpasms, InfantileChildCross-Sectional StudiesFemaleHumansInfantMaleN-AcetylglucosaminyltransferasesSeizuresSpasmALG13 protein, humanN-Acetylglucosaminyltransferasesdevelopmental and epileptic encephalopathygenetic epileptic spasmsgenetic infantile spasmsgenetic West

Identifiers

PMID37583270
PMCPMC10690684
OpenAlexW4385851747

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.